Clinical management of neurocysticercosis

References

• Del Brutto OH. Neurocysticercosis. Continuum (Minneap Minn) 2013;18(6):1392-416
   Google Scholar
• Ndimubanzi PC, Carabin H, Budke CM, et al. A systematic review of the frequency of neurocysticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 2010;4(11):e870
   PubMed Web of Science ®Google Scholar
• Del Brutto OH, Del Brutto VJ. Calcified neurocysticercosis among patients with primary headache. Cephalalgia 2012;32(3):250-4
   PubMedGoogle Scholar
• Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed Diagnostic Criteria for neurocysticercosis. Neurology 2001;57(2):177-83
   PubMed Web of Science ®Google Scholar
• Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol 2011;7(10):584-94
   PubMed Web of Science ®Google Scholar
• Singh G, Burneo JG, Sander JW. From seizures to epilepsy and its substrates: neurocysticercosis. Epilepsia 2013;54(5):783-92
   PubMed Web of Science ®Google Scholar
• Rathore C, Thomas B, Kesavadas C, et al. Calcified neurocysticercosis lesions and antiepileptic drug-resistant epilepsy: a surgically remediable syndrome? Epilepsia 2013;54(10):1815-22
   PubMed Web of Science ®Google Scholar
• Singh G, Kaushal S, Gupta M, Chander Chopra S. Cutaneous reactions in patients with solitary cysticercus granuloma on phenytoin sodium. J Neurol Neurosurg Psychiatry 2004;75(2):331-3
   PubMed Web of Science ®Google Scholar
• Del Brutto OH. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 1994;44(9):1706-9
   PubMed Web of Science ®Google Scholar
• Sharma LN, Garg RK, Verma R, et al. Seizure recurrence in patients with solitary cystic granuloma or single parenchymal brain calcification: a comparative evaluation. Seizure 2013;22(10):840-5
   PubMedGoogle Scholar
• Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercal granuloma. Neurology 2004;62(12):2236-40
   PubMed Web of Science ®Google Scholar
• Mitre E, Talaat KR, Sperling MR, Nash TE. Methotrexate as a corticosteroid-sparing in complicated neurocysticercosis. Clin Infect Dis 2007;44(4):549-53
   PubMed Web of Science ®Google Scholar
• Mejia R, Nash TE. Corticosteroid withdrawal precipitates perilesional edema around calcified Taenia solium cysts. Am J Trop Med Hyg 2013;89(5):919-23
   PubMed Web of Science ®Google Scholar
• Diazgranados-Sanchez JA, Barrios-Arrazola G, Costa JL, et al. Ivermectina como alternativa terapéutica en neurocisticercosis resistente al tratamiento farmacológico convencional. Rev Neurol 2008;46(11):671-4
   PubMedGoogle Scholar
• Moreno L, Lopez-Urbina MT, Farias C, et al. A high oxfendazole dose to control porcine cysticercosis: pharmacokinetics and tissue residue profiles. Food Chem Toxicol 2012;50(10):3819-25
   PubMedGoogle Scholar
• Sotelo J, Jung H. Pharmacokinetic optimization of the treatment of neurocysticercosis. Clin Pharmacol 1998;34(6):503-15
   Google Scholar
• Pretell EJ, Garcia HH, Gilman RH, et al. Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions. Clin Neurol Neurosurg 2001;103(3):175-7
   PubMedGoogle Scholar
• Robles C, Chavarría M. Presentación de un caso clínico de cisticercosis cerebral curado médicamente con un nuevo fármaco: praziquantel. Salud Pub Mex 1979;21(5):603-18
   PubMedGoogle Scholar
• Botero D, Castaño S. Treatment of cysticercosis with praziquantel in Colombia. Am J Trop Med Hyg 1982;31(4):811-21
   PubMedGoogle Scholar
• Spina-França A, Nobrega JPS, Livramento JA, Machado LR. Administration of praziquantel in neurocysticercosis. Tropenmed Parasitol 1982;33(1):1-4
   PubMedGoogle Scholar
• Sotelo J, Escobedo F, Rodriguez-Carbajal J, et al. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 1984;310(16):1001-7
   PubMed Web of Science ®Google Scholar
• Escobedo F, Penagos P, Rodriguez-Carbajal J, Sotelo J. Albendazole therapy for neurocysticercosis. Arch Intern Med 1987;147(4):738-41
   PubMedGoogle Scholar
• Sotelo J, Del Brutto OH, Penagos P, et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol 1990;237(2):69-72
   PubMedGoogle Scholar
• Takayanagui OM, Jardim E. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Arch Neurol 1992;49(3):290-4
   PubMedGoogle Scholar
• Garcia HH, Gilman RH, Horton J, et al. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Neurology 1997;48(5):1421-7
   PubMed Web of Science ®Google Scholar
• Wadia N, Desai S, Bhatt M. Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel. Brain 1988;111(3):597-614
   PubMedGoogle Scholar
• Kramer LD. Medical treatment of cysticercosis – ineffective. Arch Neurol 1995;52(1):101-2
   PubMedGoogle Scholar
• Del Brutto OH, Santibáñez R, Noboa CA, et al. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;42(2):389-92
   PubMed Web of Science ®Google Scholar
• Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327(10):696-701
   PubMedGoogle Scholar
• Garcia HH, Gonzalez AE, Rodriguez S, et al. Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurology 2010;75(7):654-8
   PubMed Web of Science ®Google Scholar
• Del Brutto OH. Neurocysticercosis in infants and toddlers. Report of seven cases and review of published patients. Pediatr Neurol 2013;48(6):432-5
   PubMedGoogle Scholar
• Chandi MJ, Rajshekhar V, Ghosh S, et al. Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations. J Neurol Neurosurg Psychiatry 1991;54(8):702-5
   PubMedGoogle Scholar
• Del Brutto OH, Nash TE, Garcia HH. Cysticerci-related single parenchymal brain enhancing lesions in non-endemic countries. J Neurol Sci 2012;319(1-2):32-6
   PubMedGoogle Scholar
• Del Brutto VJ, Del Brutto OH, Ochoa E, Garcia HH. Single parenchymal brain cysticercus: relationship between age of patients and evolutive stage of parasites. Neurol Res 2012;34(10):967-70
   PubMed Web of Science ®Google Scholar
• Verma A, Misra S. Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurol Scand 2006;113(3):174-7
   PubMed Web of Science ®Google Scholar
• Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in single CT ring lesions in epilepsy. Neurology 1994;44(7):1344-6
   PubMedGoogle Scholar
• Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled double-blind trial. Pediatr Infect Dis 1998;17(8):696-700
   Google Scholar
• Gogia S, Talkdar B, Choudhury V, Arora BS. Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg 2003;97(4):416-21
   PubMedGoogle Scholar
• Del Brutto OH, Roos KL, Coffey CS, Garcia HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006;145(1):43-51
   PubMed Web of Science ®Google Scholar
• Otte WM, Singla M, Sander JW, Singh G. Drug therapy for solitary cysticercus granuloma. A systematic review and meta-analysis. Neurology 2013;80(2):152-62
   PubMed Web of Science ®Google Scholar
• Singh G, Rajshekhar V, Murthy JM, et al. A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology 2010;75(24):2236-45
   PubMed Web of Science ®Google Scholar
• Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005;4(10):653-61
   PubMed Web of Science ®Google Scholar
• Garcia HH, Evans CAW, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002;15(4):747-56
   PubMedGoogle Scholar
• Nash TE, Singh G, White AC Jr, et al. Treatment of neurocysticercosis. Current status and future research needs. Neurology 2006;67(7):1120-7
   PubMedGoogle Scholar
• Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in neurocysticercosis. Natl Med J India 1995;8(6):255-8
   PubMedGoogle Scholar
• Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350(3):249-58
   PubMed Web of Science ®Google Scholar
• Carpio A, Kelvin EA, Bagiella E, et al. Effects of albendazole treatment on neurocysticercosis: a randomized controlled trial. J Neurol Neurosurg Psychiatry 2008;79(9):1050-5
   PubMed Web of Science ®Google Scholar
• Del Brutto OH. Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients. J Neurol Neurosurg Psychiatry 1997;62(6):659-61
   PubMedGoogle Scholar
• Proaño JV, Madrazo I, Avelar F, et al. Medical Treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 2001;345(12):879-85
   PubMed Web of Science ®Google Scholar
• Góngora-Rivera F, Soto-Hernández JL, Gonzalez-Esquivel D, et al. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology 2006;66(3):436-8
   PubMed Web of Science ®Google Scholar
• Fleury A, Carrillo-Mezo R, Flisser A, et al. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 2011;9(1):123-33
   PubMed Web of Science ®Google Scholar
• Cardenas G, Carrillo-Mezo R, Jung H, et al. Subarachnoid neurocysticercosis non-responsive to cysticidal drugs: a case series. BMC Neurol 2010;10:16
   PubMed Web of Science ®Google Scholar
• Márquez-Caraveo C, Góngora-Rivera F, Santos Zambrano J, et al. Pre-treatment with corticosteroids and a single cycle of high dose albendazole for subarachnoidal cysticercosis. J Neurol Neurosurg Psychiatry 2004;75(6):938-9
   PubMedGoogle Scholar
• Proaño JV, Madrazo I, Garcia L, et al. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. J Neurosurg 1997;87(1):29-33
   PubMedGoogle Scholar
• Sinha S, Sharma BS. Intraventricular neurocysticercosis: a review of current status and management issues. Br J Neurosurg 2012;26(3):305-9
   PubMed Web of Science ®Google Scholar
• Khade P, Lemos RS, Toussaint LG. What is the utility of postoperative antihelminthic therapy after resection of intraventricular neurocysticercosis? World Neurosurg 2013;79(3(4):558-67
   PubMedGoogle Scholar
• Zea-Vera A, Cordova EG, Rodriguez S, et al. Parasite antigen in serum predicts the presence of viable brain parasites in patients with apparently calcified cysticercosis only. Clin Infect Dis 2013;57(7):e154-9
   Google Scholar
• Nash TE, Del Brutto OH, Butman JA, et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2006;62(11):1934-8
   Google Scholar
• Rathore C, Radhakrishnan K. What causes seizures in patients with calcified neurocysticercal lesions? Neurology 2012;78(9):612-13
   PubMedGoogle Scholar
• Gupta RK, Awasthi R, Rathore RKS, et al. Understanding epileptogenesis in calcified neurocysticercosis with perfusion MRI. Neurology 2012;78(9):618-25
   PubMed Web of Science ®Google Scholar
• Suastegui-Roman RA, Soto-Hernández JL, Sotelo J. Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study. J Neurosurg 1996;84(4):629-33
   PubMedGoogle Scholar
• Del Brutto OH, García HH. Intramedullary cysticercosis of the spinal cord: a review of patients evaluated with MRI. J Neurol Sci 2013;331(1-2):114-17
   PubMedGoogle Scholar
• Kaur P, Dhiman P, Dhawan N, et al. Comparison of 1 week versus 4 weeks of albendazole therapy in single small enhancing computed tomography lesion. Neurol India 2010;58(4):560-4
   PubMedGoogle Scholar
• Baird RA, Zunt JR, Halperin JJ, et al. Evidence-based guideline: treatment of parenchymal neurocysticercosis. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013;80(15):1424-9
   PubMed Web of Science ®Google Scholar
• Kaur S, Singhi P, Singhi S, Khandelwal N. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J 2009;28(5):403-6
   PubMedGoogle Scholar
• Garcia HH, Lescano AG, Lanchote VL, et al. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. Br J Clin Pharmacol 2011;72(1):77-84
   PubMedGoogle Scholar